Nasdaq: TRVI
Trevi Therapeutics insiders
The officers, directors and 10% owners of Trevi Therapeutics, Inc. who hold the most stock, valued at the live TRVI price.
$13.72
TRVI today +$210K (+1.55%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 3
- Their TRVI stock
- $316M
- Market value
- $1.96B
- Held by ranked insiders
- 16.2%
Insiders by value of TRVI holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | NEA Partners 16, L.P. | 10% owner | 12,273,280 | $168M | 8.61% | Corporate |
| 2 | Nea 16 Gp, LLC | 10% owner | 10,421,428 | $143M | 7.31% | Corporate |
| 3 | David P. Meeker | Director | 352,489 | $4.8M | 0.25% | 3489th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Trevi Therapeutics; see each profile for the filing.